Word

Status

Dead

Status Code

606

Status Date

Monday, January 16, 2023

Serial Number

90647333

Mark Type

2000

Filing Date

Thursday, April 15, 2021

Published for Opposition

Tuesday, October 19, 2021

Abandoned Date

Monday, January 16, 2023

Trademark Owner History

BeiGene, Ltd. - Owner At Publication

Classifications

40 Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases

5 Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases

44 Telemedicine services; health care; convalescent home services; beauty salon services; physical therapy services; gardening; veterinary services; health counseling; pharmacy advice, namely, pharmaceutical advice; rental of sanitary installations

42 Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design

The mark consists of a shaded square in red with a stylized diamond and a star in the center of the stylized square.
The color(s) red is/are claimed as a feature of the mark.

Trademark Events

Jan 17, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 16, 2023

Abandonment - No Use Statement Filed

Apr 7, 2022

Notice Of Approval Of Extension Request E-Mailed

Apr 5, 2022

Sou Extension 1 Granted

Apr 5, 2022

Sou Extension 1 Filed

Apr 5, 2022

Teas Extension Received

Dec 14, 2021

Noa E-Mailed - Sou Required From Applicant

Oct 19, 2021

Official Gazette Publication Confirmation E-Mailed

Oct 19, 2021

Published For Opposition

Sep 29, 2021

Notification Of Notice Of Publication E-Mailed

Sep 14, 2021

Approved For Pub - Principal Register

Sep 8, 2021

Assigned To Examiner

Jul 23, 2021

Notice Of Design Search Code E-Mailed

Jul 22, 2021

New Application Office Supplied Data Entered In Tram

Apr 19, 2021

New Application Entered In Tram